Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (38)

2019

  1. Experience with the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study

    Journal of Clinical Rheumatology, Vol. 25, Núm. 6, pp. 258-263

  2. Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 63-68

2017

  1. 2016 update of the EULAR recommendations for the management of early arthritis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

  2. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202

  3. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases

    Reumatologia Clinica, Vol. 13, Núm. 4, pp. 210-213

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

  2. Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

    Clinical Rheumatology, Vol. 34, Núm. 3, pp. 563-571

  3. Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice [Clin Rheumatol, (2015), (34), 563-571, DOI 10.1007/s10067-014-2857-y]

    Clinical Rheumatology

2014

  1. Documento práctico para el uso de abatacept subcutáneo

    Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226

  2. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: Subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 94-100

2012

  1. A framework for improving the quality of care for people with psoriasis

    Journal of the European Academy of Dermatology and Venereology, Vol. 26, Núm. SUPPL. 4, pp. 1-16

  2. Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: A large, open-label study close to clinical practice

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 12, pp. 1950-1954

2011

  1. Consenso de uso de rituximab en artritis reumatoide. Un documento con recomendaciones basadas en la evidencia

    Reumatologia Clinica, Vol. 7, Núm. 1, pp. 30-44

  2. Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis

    PLoS ONE, Vol. 6, Núm. 12

2010

  1. Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker

    European Cytokine Network, Vol. 21, Núm. 3, pp. 186-194

  2. Patient perceptions concerning pain management in the treatment of rheumatoid arthritis

    Journal of International Medical Research, Vol. 38, Núm. 4, pp. 1213-1224

  3. Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 23-36

2009

  1. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial

    Journal of Bone and Mineral Research, Vol. 24, Núm. 1, pp. 153-161

2008

  1. Aggressive transformation of a quiescent primary bone lymphoma simulating Paget's disease

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 1, pp. 133-135

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20